Market Overview:
The global pharmaceutical analytical testing outsourcing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for contract research and development services, rising number of clinical trials, and growing focus on cost-effective solutions. The global pharmaceutical analytical testing outsourcing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into bioanalytical testing, method development & validation, stability testing, and others. Bioanalytical testing is further sub-segmented into in vitro diagnostics (IVD), immunoassays (IA), genomics & proteomics sequencing (GPS), chromatography & mass spectrometry (MS), microbiology assay kits & reagents; while method development & validation is further sub-segmented into dissolution test methods/validation; particle size analysis methods/validation; compendial methods/validation; water content determination methods/validation etcetera. Stability Testing are classified as accelerated stability studies or long term stability studies based on time period required for study completion). Others include physical characterization tests such as moisture content determination by Karl Fischer titration etcetera). On the basis of application, small & medium enterprise (SME) and large enterprise are two major segments in this market.
Product Definition:
Pharmaceutical Analytical Testing Outsourcing is the contracting out of pharmaceutical analysis to a third party. This can be done for a variety of reasons, such as to save time or money, or to get access to specialized equipment or expertise. Pharmaceutical analytical testing is important because it ensures that the drugs being manufactured are safe and effective. By outsourcing this work, companies can ensure that they are getting accurate and reliable results.
Bioanalytical Testing:
Bioanalytical testing is a branch of analytical chemistry which deals with the analysis of biological materials and solutions. It includes methods such as chromatography, mass spectrometry, electrophoresis, immunoassays and biochemistry. The factors that propel the growth of bioanalytical testing are increasing R&D activities in pharmaceutical & biotechnology industries for new drug development coupled with rising demand for medicines due to growing population worldwide.
Method Development & Validation:
The method development and validation is a process of creating methods and standardization of procedures for testing in the pharmaceutical industry. The main objective behind these processes is to develop reliable, precise, robust & standardized test methods that are used by all the companies for testing their products. These services also help in reducing time & cost required in performing analytical tests on samples hence increasing efficiency of manufacturing companies.
Application Insights:
The large enterprise segment dominated the global pharmaceutical analytical testing outsourcing market in 2017. This can be attributed to factors such as larger number of tests required to be performed and higher volume of product manufactured and sold by a single company. For instance, according to the Pharmaceutical Research & Manufacturers of America (PhRMA), in 2017, there were over 40 million active prescriptions for antidepressants worldwide and around 20% of these prescriptions are filled by brand-name drugs only which indicates that there is a huge unmet need for generic drugs across the world. Thus, it can be presumed that large enterprises generate more revenue through their sales than small or medium enterprises do.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of small and medium-sized enterprises coupled with high method development costs in this region has led to its dominance. Moreover, North America is home to several multinational companies that have established their research & development centers around the world for rapid product developments and commercialization at a lower cost.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as rising healthcare expenditure, increasing disposable income levels, improving healthcare infrastructure along with growing awareness regarding pharmaceutical testing services among potential customers.
Growth Factors:
- Increasing demand for generic drugs due to their low cost and efficacy is driving the growth of the pharmaceutical analytical testing outsourcing market.
- The increasing number of contract research organizations (CROs) is propelling the growth of the pharmaceutical analytical testing outsourcing market.
- The rising incidence of chronic diseases is fueling the demand for pharmaceutical analytical testing services, thereby driving the growth of this market.
- The growing focus on quality by regulatory agencies is leading to an increase in demand for pharmaceutical analytical testing services, which in turn is propelling the growth of this market. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Analytical Testing Outsourcing Market Research Report
By Type
Bioanalytical Testing, Method Development & Validation, Stability Testing, Others
By Application
Small & Medium Enterprise, Large Enterprise
By Companies
SGS SA (Switzerland), Toxikon, Inc. (US), Eurofins Scientific (Luxembourg), Pharmaceutical Product Development, LLC (US), Intertek Group plc (UK), Pace Analytical Services, LLC (US), Exova Group plc (UK), Boston Analytical (US), Charles River Laboratories International Inc. (US), West Pharmaceutical Services, Inc. (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Analytical Testing Outsourcing Market Report Segments:
The global Pharmaceutical Analytical Testing Outsourcing market is segmented on the basis of:
Types
Bioanalytical Testing, Method Development & Validation, Stability Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Small & Medium Enterprise, Large Enterprise
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SGS SA (Switzerland)
- Toxikon, Inc. (US)
- Eurofins Scientific (Luxembourg)
- Pharmaceutical Product Development, LLC (US)
- Intertek Group plc (UK)
- Pace Analytical Services, LLC (US)
- Exova Group plc (UK)
- Boston Analytical (US)
- Charles River Laboratories International Inc. (US)
- West Pharmaceutical Services, Inc. (US)
Highlights of The Pharmaceutical Analytical Testing Outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bioanalytical Testing
- Method Development & Validation
- Stability Testing
- Others
- By Application:
- Small & Medium Enterprise
- Large Enterprise
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Analytical Testing Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical analytical testing outsourcing is the process of contracting with a third-party laboratory to perform specific tests on pharmaceuticals. This service can be beneficial for companies as it allows them to save time and money by having the tests performed outside of their own facilities. Additionally, this type of outsourcing can help ensure that the products that are being distributed are safe and accurate.
Some of the key players operating in the pharmaceutical analytical testing outsourcing market are SGS SA (Switzerland), Toxikon, Inc. (US), Eurofins Scientific (Luxembourg), Pharmaceutical Product Development, LLC (US), Intertek Group plc (UK), Pace Analytical Services, LLC (US), Exova Group plc (UK), Boston Analytical (US), Charles River Laboratories International Inc. (US), West Pharmaceutical Services, Inc. (US).
The pharmaceutical analytical testing outsourcing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Analytical Testing Outsourcing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Analytical Testing Outsourcing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Analytical Testing Outsourcing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Analytical Testing Outsourcing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Analytical Testing Outsourcing Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Analytical Testing Outsourcing Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Analytical Testing Outsourcing Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Type
5.2.1 Bioanalytical Testing
5.2.2 Method Development & Validation
5.2.3 Stability Testing
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Applications
6.2.1 Small & Medium Enterprise
6.2.2 Large Enterprise
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Analytical Testing Outsourcing Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Type
9.6.1 Bioanalytical Testing
9.6.2 Method Development & Validation
9.6.3 Stability Testing
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Applications
9.10.1 Small & Medium Enterprise
9.10.2 Large Enterprise
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Analytical Testing Outsourcing Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Type
10.6.1 Bioanalytical Testing
10.6.2 Method Development & Validation
10.6.3 Stability Testing
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Applications
10.10.1 Small & Medium Enterprise
10.10.2 Large Enterprise
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Type
11.6.1 Bioanalytical Testing
11.6.2 Method Development & Validation
11.6.3 Stability Testing
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Applications
11.10.1 Small & Medium Enterprise
11.10.2 Large Enterprise
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Analytical Testing Outsourcing Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Type
12.6.1 Bioanalytical Testing
12.6.2 Method Development & Validation
12.6.3 Stability Testing
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Applications
12.10.1 Small & Medium Enterprise
12.10.2 Large Enterprise
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Analytical Testing Outsourcing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Type
13.6.1 Bioanalytical Testing
13.6.2 Method Development & Validation
13.6.3 Stability Testing
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Analytical Testing Outsourcing Market Size Forecast by Applications
13.10.1 Small & Medium Enterprise
13.10.2 Large Enterprise
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Analytical Testing Outsourcing Market: Competitive Dashboard
14.2 Global Pharmaceutical Analytical Testing Outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SGS SA (Switzerland)
14.3.2 Toxikon, Inc. (US)
14.3.3 Eurofins Scientific (Luxembourg)
14.3.4 Pharmaceutical Product Development, LLC (US)
14.3.5 Intertek Group plc (UK)
14.3.6 Pace Analytical Services, LLC (US)
14.3.7 Exova Group plc (UK)
14.3.8 Boston Analytical (US)
14.3.9 Charles River Laboratories International Inc. (US)
14.3.10 West Pharmaceutical Services, Inc. (US)
